Men are more likely than women to develop colon cancer, and hormone-replacement therapy in postmenopausal women reduces its incidence, suggesting a protective role for estrogen/ER in the development of this disease [173, 174]. The gene discussed is ESR1; the disease is colonic neoplasm.